Real-world effectiveness of early molnupiravir or nirmatrelvir–ritonavir in hospitalised patients with COVID-19 without supplemental oxygen requirement on admission during Hong Kong's omicron BA.2 wave: a retrospective cohort study
収録刊行物
-
- The Lancet Infectious Diseases
-
The Lancet Infectious Diseases 22 (12), 1681-1693, 2022-12
Elsevier BV